Alto Neuroscience (ANRO) Other Non Operating Income (2025)

Alto Neuroscience (ANRO) reported Other Non Operating Income of -$681000.0 for Q1 2025.

Alto Neuroscience (ANRO) Other Non Operating Income (2025) Analysis & Trends

Alto Neuroscience (ANRO) has 1 years of Other Non Operating Income data on file, last reported at -$681000.0 in Q1 2025.

For the quarter ending Q1 2025, Other Non Operating Income changed N/A year-over-year to -$681000.0; the trailing twelve-month figure through Dec 2025 stood at -$681000.0 (changed N/A YoY), and the FY2025 full-year result was -$681000.0, changed N/A from the prior year.
Other Non Operating Income steadied at -$681000.0 in Q1 2025.
In the past five years, Other Non Operating Income ranged from a high of -$681000.0 in Q1 2025 to a low of -$681000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn
7	Belite Bio	61.40 Bn	61.40 Bn	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn
9	Revolution Medicines	37.37 Bn	37.37 Bn	-
10	Alto Neuroscience	869.36 Mn	869.36 Mn	-

Download Data

Date	Value
Mar 31, 2025	-681,000.00